Predicting pathological response after ipilimumab plus nivolumab in stage III urothelial cancer by liquid-biopsy assessment of plasma and urine ctDNA using the RaDaR assay
Actionable fusions detected by RNA-seq co-occur with PD-L1 expression and driver mutations in solid tumors patients
Comprehensive characterization of the biology of inflammatory bowel disease-associated colorectal cancer using the GeoMx® Digital Spatial Profiler (DSP)
Custom PhenoImager™ fluorescent multiplex IHC panel identifies mature tertiary lymphoid structures in colorectal cancer
Dual approach using proteomics and multiplexed immunofluorescence for the detection of markers predictive for immunotherapy in melanoma patients
Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development
Molecular profiling of RUNX1/RUNT domain in myeloid disorders
Obesity-Induced Changes in the Tumor Microenvironment Impact the Response to Chemotherapy and Overall Ovarian Cancer Metastatic Success